J Mitra Launches India’s First Dengue NS1 Antigen Self-Test

New Delhi: J Mitra & Company has revitalised its war against dengue by launching the Dengue NS1 Antigen self-test kit. This is the first self-test/home-test kit launched by any company in India.

It detects dengue on the first day of fever; it is self-administrable – anyone can conduct the test on their own and in any location; Results are available within 20 mins.

Using the Dengue NS1 Antigen self-test is a straightforward, 2-step process – add one drop of blood into the sample well; add one drop of assay buffer; allow the reaction to occur for 20 minutes and read the result.

The Dengue NS1 Antigen self-test is a proactive tool that can detect the Dengue NS1 Antigen from Day One as soon as the symptoms appear in patients. This early detection capability empowers individuals to take control of their health and seek timely medical intervention. NS1 Antigen can be detected in both primary and secondary dengue infections. However, NS1 is challenging to detect once anti-NS1 Antibodies appear. NS1 Antigen is present at high concentrations in the sera of Dengue virus-infected patients during the early clinical phase of the disease.

Dengue is amongst the top 10 most communicable diseases in India, and the most affected states include Uttar Pradesh, West Bengal, Bihar, Karnataka, Maharashtra, Kerala, Delhi, Rajasthan, Punjab and Odisha.

Related Posts

Gene Therapy for Cholesterol: Initial Test Results Cheer

Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gene Therapy for Cholesterol: Initial Test Results Cheer

Gene Therapy for Cholesterol: Initial Test Results Cheer

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states